Paper20520719
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M and 8 others. PLoS One, 2010. Cited by 123 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. Papers, record 20520719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20520719
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Gene Transfer Techniques | Major topic |
| Nanoparticles | Major topic |
| Osteosarcoma | Major topic |
| RNA, Small Interfering | Major topic |
| ATP Binding Cassette Transporter, Subfamily B | |
| Animals | |
| Blotting, Western | |
| Cell Death | |
| Cell Line, Tumor | |
| Dextrans | |
| Doxorubicin | |
| Fluoresceins | |
| Green Fluorescent Proteins | |
| Humans | |
| Intracellular Space | |
| Lipids | |
| Subcellular Fractions |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA119617 | NCI NIH HHS | United States | R01CA119617 | PubMed and NIH |
| R01-CA119617 | NCI NIH HHS | United States | R01CA119617 | PubMed and NIH |
Source NIH RePORTER
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16831079 | Chemotherapy resistance in osteosarcoma: current challenges and future directions. | Expert Rev Anticancer Ther | 2006 | https://conductscience.org/library/papers/16831079 | PubMed |
| 2 | 7912530 | Taxol: mechanisms of action and resistance. | J Natl Cancer Inst Monogr | 1993 | https://conductscience.org/library/papers/7912530 | PubMed |
| 3 | 7879670 | Multidrug resistance in the laboratory and clinic. | Adv Clin Chem | 1994 | https://conductscience.org/library/papers/7879670 | PubMed |
| 4 | 1816768 | Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected]. | Eur J Cancer | 1991 | https://conductscience.org/library/papers/1816768 | PubMed |
| 5 | 19917123 | Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19917123 | PubMed |
| 6 | 9408960 | Pharmacologic approaches to reversing multidrug resistance. | Semin Hematol | 1997 | https://conductscience.org/library/papers/9408960 | PubMed |
| 7 | 2946403 | A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. | Cancer Res | 1986 | https://conductscience.org/library/papers/2946403 | PubMed |
| 8 | 9627221 | Cytometric study of intracellular P-gp expression and reversal of drug resistance. | Cytometry | 1998 | https://conductscience.org/library/papers/9627221 | PubMed |
| 9 | 1671173 | Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1671173 | PubMed |
| 10 | 16952261 | Nonfouling characteristics of dextran-containing surfaces. | Langmuir | 2006 | https://conductscience.org/library/papers/16952261 | PubMed |
| 11 | 17096323 | Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J. | Int J Cancer | 2007 | https://conductscience.org/library/papers/17096323 | PubMed |
| 12 | 15514371 | Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15514371 | PubMed |
| 13 | 2565763 | Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. | Cancer Res | 1989 | https://conductscience.org/library/papers/2565763 | PubMed |
| 14 | 17393074 | Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. | Pharm Res | 2007 | https://conductscience.org/library/papers/17393074 | PubMed |
| 15 | 11033070 | Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. | Eur J Pharm Sci | 2000 | https://conductscience.org/library/papers/11033070 | PubMed |
| 16 | 1968358 | Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. | Cancer Res | 1990 | https://conductscience.org/library/papers/1968358 | PubMed |
| 17 | 10728603 | Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10728603 | PubMed |
| 18 | 13650640 | Tissue sulfhydryl groups. | Arch Biochem Biophys | 1959 | https://conductscience.org/library/papers/13650640 | PubMed |
| 19 | 16935749 | Exploiting the enhanced permeability and retention effect for tumor targeting. | Drug Discov Today | 2006 | https://conductscience.org/library/papers/16935749 | PubMed |
| 20 | 8102521 | Biochemistry of multidrug resistance mediated by the multidrug transporter. | Annu Rev Biochem | 1993 | https://conductscience.org/library/papers/8102521 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42388536 | Enhanced endosomal escape for nanoparticle-enabled co-delivery of doxorubicin and siRNA to overcome multidrug resistance. | Mater Today Adv | 2026 | https://conductscience.org/library/papers/42388536 | PubMed |
| 42082974 | Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42082974 | PubMed |
| 41789800 | Small Interfering RNA Strategies to Overcome Drug Resistance in Cancer: Pathway Targeting and Translational Advances. | Eurasian J Med | 2026 | https://conductscience.org/library/papers/41789800 | PubMed |
| 41779304 | N-benzylbenzamide derivative (SBM685) as a novel MDR1 inhibitor for overcoming 5 fluorouracil resistance in gastric cancer through computational and in vitro analysis. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41779304 | PubMed |
| 40098719 | Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40098719 | PubMed |
| 38616741 | SiRNA-mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38616741 | PubMed |
| 38204162 | The landscape of nanoparticle-based siRNA delivery and therapeutic development. | Mol Ther | 2024 | https://conductscience.org/library/papers/38204162 | PubMed |
| 37646049 | Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells. | Adv Pharm Bull | 2023 | https://conductscience.org/library/papers/37646049 | PubMed |
| 34977908 | Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters. | Free Neuropathol | 2021 | https://conductscience.org/library/papers/34977908 | PubMed |
| 34336608 | Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy. | Bioimpacts | 2021 | https://conductscience.org/library/papers/34336608 | PubMed |
| 32599901 | Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32599901 | PubMed |
| 32181109 | The potential of micelleplexes as a therapeutic strategy for osteosarcoma disease. | 3 Biotech | 2020 | https://conductscience.org/library/papers/32181109 | PubMed |
| 31882620 | Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids. | Sci Rep | 2019 | https://conductscience.org/library/papers/31882620 | PubMed |
| 31498151 | Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31498151 | PubMed |
| 31319571 | In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31319571 | PubMed |
| 31227171 | Review of polysaccharide particle-based functional drug delivery. | Carbohydr Polym | 2019 | https://conductscience.org/library/papers/31227171 | PubMed |
| 31111296 | Nanoparticles: Oral Delivery for Protein and Peptide Drugs. | AAPS PharmSciTech | 2019 | https://conductscience.org/library/papers/31111296 | PubMed |
| 30940690 | Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/30940690 | PubMed |
| 30609256 | Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30609256 | PubMed |
| 30108690 | Adaptive mechanisms of resistance to anti-neoplastic agents. | Medchemcomm | 2017 | https://conductscience.org/library/papers/30108690 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 | NCBI Gene |
| ABCC2 | 1244 | PubTator's text mining | https://conductscience.org/library/genes/1244 | NCBI Gene |
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| OSR2 | 116039 | PubTator's text mining | https://conductscience.org/library/genes/116039 | NCBI Gene |
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20520719
GET https://conductscience.org/api/papers/v1/20520719/references?page=2